Good Progress in Phase 1 Study of MediGene`s Novel Anticancer Therapeutic NV1020 to Treat Colorectal Cancer Metastatic to the Liver
(PR Newswire)...This combination of properties makes NV1020 ideally suited as a unique anti-tumor therapeutic.......MediGene recently announced that its other modified HSV-1 anticancer candidate, G207, for treatment of brain tumors, has successfully completed phase 1 clinical trials and is about to enter further clinical development....- Mar 21 8:31 AM ET
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/prnews/010321/lnw010.html
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines